Tela Bio Inc (TELA)

Currency in USD
1.940
-0.040(-2.02%)
Closed·
After Hours
1.9400.000(0.00%)
·
TELA Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 11 days
Fair Value
Day's Range
1.8802.130
52 wk Range
0.8654.460
Key Statistics
Prev. Close
1.98
Open
2.02
Day's Range
1.88-2.13
52 wk Range
0.865-4.46
Volume
55.12K
Average Volume (3m)
113.86K
1-Year Change
-56.21%
Book Value / Share
0.46
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.600
Upside
+188.66%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Tela Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Tela Bio Inc Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Tela Bio Inc SWOT Analysis


Biologic Innovation
TELA Bio's OviTex platform disrupts hernia repair and reconstructive surgery markets with biocompatible, cost-effective solutions aligned with industry shifts
Financial Challenges
Despite record revenues and strong margins, TELA faces cash burn issues and ongoing losses, prompting efficiency measures to reduce expenses
Market Dynamics
Explore TELA's positioning amidst fierce competition, including aggressive talent poaching by smaller wound care companies impacting sales performance
Growth Trajectory
Analysts project sales reaching $105.5M by 2026, with price targets ranging from $7 to $12, reflecting cautious optimism despite near-term headwinds
Read full SWOT analysis

Tela Bio Inc Earnings Call Summary for Q1/2025

  • Tela Bio's Q1 2025 revenue of $18.5M missed forecasts, but stock rose 9.04% in aftermarket trading to $1.08
  • OviTex product lines showed strong growth, with OviTex revenue up 15% year-over-year
  • Company projects full-year 2025 revenue of $85-88M, representing 23-27% growth
  • Potential tariffs on New Zealand-manufactured products could impact gross margins by 50-100 basis points
  • CEO emphasized long-term strategy, stating 'This is a marathon. It's not a sprint.'
Last Updated: 08/05/2025, 22:20
Read Full Transcript

Compare TELA to Peers and Sector

Metrics to compare
TELA
Peers
Sector
Relationship
P/E Ratio
−1.8x−4.2x−0.5x
PEG Ratio
−0.08−0.300.00
Price/Book
4.2x2.6x2.6x
Price / LTM Sales
1.1x4.1x3.3x
Upside (Analyst Target)
204.4%34.6%42.4%
Fair Value Upside
Unlock6.6%7.2%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.600
(+188.66% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.25 / -0.20
Revenue / Forecast
18.50M / 21.05M
EPS Revisions
Last 90 days

TELA Income Statement

People Also Watch

16.75
SRPT
+5.81%
267.80
AVAV
-0.22%
2.070
ONDS
+13.74%
6.780
LIMN
+1.35%
225.19
LEU
+0.50%

FAQ

What Stock Exchange Does Tela Bio Trade On?

Tela Bio is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tela Bio?

The stock symbol for Tela Bio is "TELA."

What Is the Tela Bio Market Cap?

As of today, Tela Bio market cap is 77.53M.

What Is Tela Bio's Earnings Per Share (TTM)?

The Tela Bio EPS (TTM) is -1.29.

When Is the Next Tela Bio Earnings Date?

Tela Bio will release its next earnings report on 10 Aug 2025.

From a Technical Analysis Perspective, Is TELA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Tela Bio Stock Split?

Tela Bio has split 0 times.

How Many Employees Does Tela Bio Have?

Tela Bio has 209 employees.

What is the current trading status of Tela Bio (TELA)?

As of 31 Jul 2025, Tela Bio (TELA) is trading at a price of 1.94, with a previous close of 1.98. The stock has fluctuated within a day range of 1.88 to 2.13, while its 52-week range spans from 0.87 to 4.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.